Dabigatran (Pradaxa).
AJNR Am J Neuroradiol
; 33(3): 426-8, 2012 Mar.
Article
em En
| MEDLINE
| ID: mdl-22345499
ABSTRACT
Dabigatran (Pradaxa) is a member of the relatively new class of antithrombotic drugs known as direct thrombin inhibitors (DTIs). It may supplant warfarin (Coumadin) in a number of applications as it may produce a more predictable, potent, and immediate anticoagulant effect, with fewer significant side effects and interactions, and requires less monitoring.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Trombose
/
Benzimidazóis
/
Beta-Alanina
/
Hemorragia
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article